WrapManager Inc’s Dr. Reddy's Laboratories RDY Stock Holding History

WrapManager Inc’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-14,155	Closed	-$202K	–	298
2020 Q4	$202K	Buy	+14,155	New	+$191K	0.06%	258

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

WrapManager Inc's RDY Position: Q1 2021 in Review

WrapManager Inc sold out of Dr. Reddy's Laboratories (RDY) in Q1 2021, closing a stake of 14,155 shares — an estimated $202K sold.

WrapManager Inc first reported a position in RDY in Q4 2020 and held it in 1 quarter. The position peaked at $202K in Q4 2020. 160 funds tracked by Wall St. Rank hold RDY as of Q1 2021.

WrapManager Inc reported no remaining Dr. Reddy's Laboratories position as of Q1 2021 after selling out during the quarter.
WrapManager Inc sold 14,155 Dr. Reddy's Laboratories shares in Q1 2021, an estimated $202K.
WrapManager Inc first reported a position in Dr. Reddy's Laboratories in Q4 2020 and held it in 1 quarter.
WrapManager Inc's Dr. Reddy's Laboratories position peaked at $202K in Q4 2020.
160 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2021.

Based on WrapManager Inc's 13F filing for Q1 2021, filed 10 May 2021.